Therefore, the transition from the asymptomatic preclinical stage into symptomatic stages of AD may be associated with the propagation of tau pathology into the Aβ plaque-rich cortex, suggesting a collaborative interaction between the two aggregates toward AD progression (Busche et al., 2019). Here, MAPT is linked to Alzheimer disease.